Verified stock metrics
Entrada Therapeutics, Inc. - Common Stock Key Stock Metrics
Entrada Therapeutics, Inc. - Common Stock (TRDA) market cap, valuation, profita…
Direct answer
Entrada Therapeutics, Inc. - Common Stock has 8 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked August 7, 2026.
Verified data
- Market capitalization
- $264.77M
- Price-to-book ratio
- 0.9x
- Dividend yield
- 0%
- 52-week price range
- $4.93 to $16.45
- Return on equity
- -54.1%
- Revenue growth
- -53.9%
- Profit margin
- 0%
- Debt-to-equity ratio
- 20.8%
Explore related company data
View Entrada Therapeutics, Inc. - Common Stock's market capitalizationView Entrada Therapeutics, Inc. - Common Stock's price-to-book ratioView Entrada Therapeutics, Inc. - Common Stock's dividend yieldView Entrada Therapeutics, Inc. - Common Stock's 52-week price rangeView Entrada Therapeutics, Inc. - Common Stock's return on equityView Entrada Therapeutics, Inc. - Common Stock's revenue growthView Entrada Therapeutics, Inc. - Common Stock's profit marginView Entrada Therapeutics, Inc. - Common Stock's debt-to-equity ratioReturn to Entrada Therapeutics, Inc. - Common Stock profile